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INTRODUCTION 
Relief of Pain is purchased always at a price – Ralph Waters.  
“For all the happiness mankind can gain is not in pleasure but in rest 
from pain”. – John Dyrden.  
The aim of anesthesiology as a science is the removal of pain 
temporarily started initially with pain relief for surgeries, extending now to 
post operative pain relief, relief of chronic pain and cancer pain. 
Spinalanesthesia plays in important role of alleviating pain intra-
operatively, extending sometime into postoperative period also. The entry 
of Corning’s needle in 1885-into the subarachnoid space paved the way for 
the greatest leap into spinal anaesthesia. His words “Be the density of this 
observation, what it may have seemed to me on the whole, worth 
recording. This opened the prologue for the word “spinal anaesthesia”. 
Cocaine was the drug first used experimentally in dogs. In men the first 
spinal anaesthesia was conducted by “August Bier” on 16.8.1898 with 
cocaine 3 ml as 0.5% solution followed by Matas in America and Tuffier in 
France.  
Spinal anesthesia for caesarean section has always enjoyed 
popularity as it eliminates the complication of pulmonary aspiration and 
avoids the problem of difficult tracheal intubation observed with general 
anaesthesia. Other advantages of this technique are its simplicity, rapid 
onset and dependability.  
The demonstration of opiate receptors in substantia gelatinosa of 
spinal cord (Yaksh and Rudy 1976) has created interest in the intrathecal 
administration of opiates. The use of intrathecal morphine for providing 
postoperative pain relief in caesarean section was started in the year 1988 
by EzzazAboulesish et.al. The advantages of neuraxial opioids over 
neuraxial local anesthetics are that it produces prolonged, intense, 
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selective, segmental analgesia without motor blockade and sympathetic 
dysfunction.  
Opiods and local anesthetics administered together have a potent 
synergistic analgesic effect. Intrathecal opiods enhance analgesia from 
subtherapeutic dose of local anesthetic and make it possible to achieve 
successful spinal anaesthesia using otherwise inadequate doses of local 
anesthetic. The α2 adrenergicmechanism have been exploited for more 
than 100 yrs. Vetenarians have used α2 agonist for many years for regional 
analgesia, but the experience with these agents in humans, dates back 
only slightly more than 10 years.  
In 1984 Tamsen, Gordh after testing neurotoxicity in animals and 
then injected a parenteral preparation of α2 agonist clonidine, epidurally 
intwo patients with chronic pain. Since then the complete toxicologic 
assessment in animal studies has suggested that clonidine is safe for 
Intrathecal use.  
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AIM OF THE STUDY 
1. To evaluate the effects of fentanyl and clonidineadded to 
Bupivacaine, for caesarean section in spinal Anaesthesia  
2. To evaluate the duration of analgesia by comparing two groups.  
3. To evaluate the hemodynamic effects, post-operative sedation 
and neonatal outcome between the two groups.  
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ANATOMY OF SUBARACHNOID SPACE 
 Subarachnoid block means privation of senses not necessarily 
implying loss of consciousness.  
APPLIED ANATOMY OF VERTEBRAL CANAL  
 The vertebral canal extends from foramen magnum to the sacral 
hiatus. It protects the spinal cord. Vertebral canal is formed by 7-cervical, 
12-thoracic, 5-lumbar, 5-sacral and 4-coccygeal vertebrae. Each vertebra 
is composed of a ‘body’ separated from the adjacent vertebra by 
intervertebral disc and ‘vertebral arch’ formed by pedicles and laminae, 
which surround and protect the cord laterally and posteriorly.  
VERTEBRAL LIGAMENTS BOUNDING THE CANAL  
1. Supraspinous ligament – passes longitudinally over the tips of 
spinous processes from C7 to the sacrum. 
2. Interspinous ligament-joining the spinous process together.  
3. Ligamentum flavum-Running from laminae to laminae, composed of 
yellow elastic fibres. Half of the posterior wall is composed of the 
bony laminae and half by the ligamentum flavum. They become 
progressively thicker from above downwards.  
4. Posterior longitudinal ligament-on posterior surface of bodies of 
vertebrae.  
5. Anterior longitudinal ligament-runs along the front of the vertebral 
bodies.  
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There are seven projections from these vertebral or neural arches.  
They are: 
a) Three muscular processes – two transverse and one 
spinous-for the attachment of muscles and ligaments and  
b) Four articular processes – two upper and two lower – which 
in the lumbar region, prevent rotation but allow limited 
flexion and extension between contiguous vertebrae.  
Vertebral canal formed by these structures, has deficiencies 
posteriorly in the midline, called inter laminar foramina, which enlarge in 
flexion accessible for the passage of spinal needle. The direction of 
spinous process determines the direction of the spinal needle. 
SPINAL CORD  
It is the direct continuation of medulla oblongata extending from 
upper border of atlas to 1st lumbar vertebra, below which there is leash of 
nerve roots termed caudaequina. Spinal nerves are 31 pairs totally.  
 8 - Cervical 
 12 – Thoracic 
 5 – Lumbar 
 5 – Sacral  
 1 – Coccygeal 
 Each of the spinal nerve is composed of anterior and posterior roots 
uniting at the inter vertebral foramina and form a nerve trunk.  
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Membranes covering the spinal cord from without are duramater, 
arachanoidmater and piamater. Dura and arachnoid end at S2 level.Piais 
closely applied to the spinal cord. 
Blood Supply 
It is from the anterior spinal artery which is a branch of vertebral 
artery and also by a pair of posterior spinal arteries which arise from 
posterior inferior cerebellar arteries. There is no anastomosis between 
these arteries.  
Spinal Veins  
The spinal veins are arranged into anterior and posterior plexus which are 
draining into vertebral, azygos and lumbar veins.  
Cerebro Spinal Fluid (CSF) 
 It is the ultrafiltrate of plasma from choroidal plexus of lateral 
ventricles with a pH of 7.4.The amount of cerebro spinal fluid in spinal 
canal is 75 ml with a pressure of 70-170 mm of water in lateral position.  
 It contains  20-40 mg % protein  
   45-80 mgs% sugar 
   0-5 lymphocytes / cmm normally  
 An important factor that determines the spread of drug in CSF is the 
specific gravity of the drug in relation to that of CSF (baricity) which is 
1.003-1.009 (average 1.004). Hyperbaric solution is one which is denser 
than CSF at 370C. 
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PHYSIOLOGY OF SUBARCHNOID BLOCK 
 Subarachnoid block implies temporary interruption of nerve 
transmission within the spinal space by injection of drugs into the space. 
The blockade occurs in the order of first preganglionic βfibres, temperature, 
pain, proprioception and then motor fibres.  
Factors controlling the extent and duration of anaesthesia  
1. Specific gravity of the solution – the most important  
2. Position of the patient during and immediately after injection  
3. Site of injection 
4. Volume and concentration of the solution: increasing the dose 
and concentration prolongs the effect. 
5. Patient factors like age, height and pregnancy.  
Effects on cardiovascular system 
The most important physiological response to spinal 
anesthesiainvolves the CVS due to the combined effects of autonomic 
denervation and vagal nerve innervations at higher levels. βfibres are more 
sensitive than alphafibres causing a higher sympathetic block (zone of 
differential blockade) resulting in vasodilatation and a fall in blood pressure 
especially if a substantial number of thoracic segments are blocked. Due to 
Bainbridge reflex, the fall in blood pressure is associated with bradycardia. 
Blockade of cardiac sympathetic fibres is from T1—T4, an additional factor 
that causes bradycardia. 
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Effects on respiratory system  
Respiration is not depressed normally. High spinal can-cause 
paralysis of intercostals muscles but resting tidal volume, maximum 
inspiratory volume and negative intrapleural pressure and also the phrenic 
nerve are unaffected. Hypoxia may accompany hypotension and is 
corrected by oxygen via face mask. 
Metabolic and hormonal effects  
 Spinal anesthesia blocks hormonal and metabolic responses to 
nociceptive stimuli arising from the operative site. It minimizes the rise in 
blood sugar, cortisol, catecholamines, rennin and aldosterone release 
associated with stress. Postoperative negative nitrogen balance and 
secretion of antidiuretic hormone are inhibited.  
Hepatic and Renal Effects  
 The hepatic blood flow decreases and is directly proportional to the 
decrease in blood pressure. There may be more of hepatic oxygen 
extraction. Renal blood flow is maintained by autoregulation and does not 
decrease till mean arterial pressure go below 50 mmHg. 
Thermoregulation and Shivering  
 Hypothermia results from heat loss to the cold environment due to 
vasodilatation.  
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Genitourinary Systems 
 Sphincters of bladder are not relaxed, and tones of ureters are not 
greatly altered. Penis is often engorged and flaccid due to paralysis of 
nerve-erigentes (S2, 3). Postspinal retention of urine may be moderately 
prolonged as L2 and L3 contain small automatic fibres and their paralysis 
lasts longer than that of the larger sensory and motor fibres. Uterine tone is 
unchanged in pregnancy. In the absence of hypotension, spinal 
anaesthesia has got no effect on the progress of labour and uterine blood 
flow.  
Gastrointestinal Effects  
 Preganglionic fibresfrom T5 to L4 are inhibitory to gut. So in 
sympathetic blockade the small intestine contracts with relaxed sphincters 
and peristalsis remain normal. Handling of viscera causes discomfort and 
bradycardia since vagus is not blocked.  
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HISTORY OF PAIN 
 An anesthesiologist has a role to relive pain due to various causes 
including post-operativepain. Pain – The word derived from a Greek word 
“poine’ which means penalty. Pain is defined as an unpleasant sensory 
and emotional experience which is associated with actual tissue damage or 
potential tissue damage or at leastdescribed in terms of such damage. 
Aristotle – Described that the pain was an emotion emanating from the 
heart. Galen - Correctly observed brain was required to manifest the pain 
and he also proposed that sensation is a property of nervous tissue.  
The idea of specific neural pathways for painful sensations began with 
CHARLES BELL (1774-1842) and FRANCOIS MAGENDIE (1783-1855) 
who both demonstrated that dorsal roots of the spinal cord transmit 
sensory information and the ventral root transmit the motor information. In 
1948 Ahlquist proposed the designations of α and β receptors. Since then 
various subtypes of these two main classes have been characterized. 
Various theories regarding pain transmission including gate control theory 
(1965) by Melzack and Wall. Endogenous opioids are located at diverse 
sites in the pain pathway, including dorsal horn of spinal cord which 
influencesthe rostral transmission of Pain. By using intrathecal or epidural 
injection, the nociceptive transmission at the 1stsynptic relay in the spinal 
cord may be manipulated.  
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PHYSIOLOGY OF LABOUR PAIN 
UTERINE AND CERVICAL PAIN  
 The afferent nerve fibres that pass from the uterus and the cervix are 
somatic sensory fibres which travel via the sympathetic nerves supply of 
the uterus. These fibres pass through the paracervical tissue along the 
uterine artery, and then through the inferior, middle and superior 
hypogastric plexus to the sympathetic chain. These impulses then enter 
the spinal cord through the 10, 11 and 12th thoracic nerves.  
PERINEAL PAIN  
 Impulses arising from the vagina, vulva and perineum travel in a 
different pathway. Sensory innervation of this area is through the pudental 
nerve which enters the central nervous system via 2, 3, 4 sacral nerves.  
CENTRAL NERVOUS SYSTEM (CNS) 
 Upon entering the CNS, these impulses undergo modulating in the 
posterior horn of the spinal cord. Many neurotransmitters mainly 
enkephalin, endorphins, serotonin, γaminobutyric acid (GABA), dopamine 
and epinephrine all participate in the process of conduction of pain 
impulses and play a role in whether a painful stimulus will ultimately 
produce the sensation of pain. Obviously applying either of these 
neurotransmitters or analogues thereof (i.e. Opiate drugs) to the spinal 
cord or brain can also affect the transmission of pain within the CNS. It is 
this realization that forms the physiological and pharmacological basis for 
the application of narcotics within the spinal canal to produce analgesia. 
 If the synaptic modulations in the dorsal horn permits upward 
transmission of the stimulus, it will travel upward primarily via the neo and 
palaeo-spinothalamic tracts.  
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These impulses can then stimulates the reticular formation and segmental 
tract in the brain stem and then continue upward to the ventral 
posterolateralnucleus of the thalamus. From here, fibres project to the 
sensory cortex for localization and discrimination of pain. Adequate 
obstetric analgesia not only reduces the physiological or subjective 
component of pain but may also be beneficial in preventing undesirable 
reflex effects. The administration of opiates to produce analgesia either for 
labour or following caesarean delivery has long been an useful technique 
by which analgesia can be reliably produced. A number of methods 
(intramuscular, intravenous, continuous intravenous infusion, patient 
controlled analgesia etc.,) have been successfully used to produce 
analgesia.  
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PHYSIOLOGICAL CHANGES DURING PREGNANCY 
BODY CONSTITUENTS  
 Intravascular fluid volume  +35% 
 Plasma     + 45% 
 RBC     + 20% 
CARDIO VASCULAR FUNCTION  
 Cardiac output   +40% 
 Stroke volume   +30% 
Heart rate    +15% 
PERIPHERAL CIRCULATION  
 Systolic     : No changes  
 Systemic vascular resistance  : -15 
 Diastolic     : -15 
 Central Venous pressure  : No change  
 Femoral venous pressure  : +15 
RESPIRATORY FUNCTION  
 Average changes from non pregnant value  
 Minute ventilation    : + 50% 
 Tidal volume    : + 40% 
 Breathing Rate    : + 10 
 PaO2     : + 10 mm Hg 
 PaCO2    : - 10 mm Hg  
 pH     : No change  
 Total lung capacity   : No change  
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 Vital capacity    : No change  
 FRC      :  - 20% 
 Expiratory Reserve volume  :   -20% 
 Residual Volume    :   -20% 
 Airway resistance    : -35% 
 Oxygen consumption   : +20% 
 BMR      :   + 15 -20% 
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PHYSIOLOGICAL CHANGES DURING PREGNANCY 
Body constituents  
 Blood volume begins to increase in the first trimester and reaches 
50% above the non pregnant level in the third trimester. The red blood cell 
mass also-rises steadily but relatively less than total blood volume with a 
consequent reduction in hemoglobin concentration deposits a raised total 
hemoglobin content.  
CARDIOVASCULAR FUNCTION  
 Cardiac output, myocardial contractility, heart rate and stroke volume 
are increased. The increase in cardiac output starts in the first trimester. 
Arteriovenous oxygen content difference is reduced until the final month. 
Systematic vascular resistance is decreased. No change occurs in 
pulmonary arterial pressure during pregnancy. Blocking the autonomic 
nervous system may result in dramatic decrease in systematic arterial 
pressure during pregnancy, suggesting a chronically active sympathetic 
tone.  
RESPIRATORY FUNCTION  
 Respiratory tract is oedematous due to capillary engorgement. 
Functional residual capacity is decreased. Although the enlarging uterus 
causes elevation of diaphragm, total lung capacity and vital capacity 
remain unchanged due to compensatory increase in the antero-posterior 
and transverse diameters of chest. The minute volume increases in late 
pregnancy due to increase in tidal volume and respiratory rate with an 
increase in oxygen consumption.  
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RENAL FUNCTION  
 Changes in renal function are mainly due to increased levels of 
ACTH. ADH, aldosterone, cortisol and thyroid hormone. Glomerular 
filtration rate starts increasing early and remains at about 40% above non-
pregnant levels by mid pregnancy. Renal plasma flow also increases as 
much as 50 percent and peaks by the end of the second trimester, 
remaining high until term.  
GASTRO INTESTINAL FUNCTION  
 Gastro intestinal motility decreases due to a direct effect of 
progesterone and also by an inhibitory effect of progesterone on plasma 
motilin. The lower oesophageal sphincter tone is diminished.  
HEPATIC FUNCTION  
 There are no grass morphological changes but functional changes 
are present in the liver. The plasma cholinesterase level is decreased 
significantly as early as the first trimester and remains low until delivery.  
COAGULATION AND FIBRINOLYTIC FUNCTIONS  
 Plasma levels of factors VII, X, XII and fibrinogen increase during 
pregnancy, leading to a hyper coagulable state.  
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EVALUATION OF THE NEONATE  
 The importance of assessment of neonate immediately after birth is 
to promptly treat the depressed infants, who require active resuscitation. 
As a guide to identify and to treat the depressed neonate, Apgar score is 
used.  
APGAR SCORE  
 Virginia Apgar of New York City described a system whereby the 
condition of a neonate can be assessed at one minute and 5 minutes after 
delivery. The Apgar score has been shown to correlate well with acid-base 
measurements performed immediately after birth. 
EVALUATION OF NEWBORN INFANT USING APGAR SCORE  
Sl.No. Signs  Scores 
0 1 2 
1 Heart rate  Absent  <100/mt. > 100/mt 
2 Respiratory effort  Absent  Slow, irregular  Crying  
3 Reflex irritability  No response  Grimace  Cry 
4 Muscle tone  Limp Hypotonia Active  
5 Color  Pale, cyanotic  Body pink; 
extremities 
cyanotic  
Pink  
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TIME FOR SUSTAINED RESPIRATION  
 The time interval between delivery and the establishment of 
sustained respiration has been used to identify the depressed neonate. A 
time for sustained respiration greater than 90 sec. indicates a depressed 
neonate and correlates with Apgar score of 6 or less.  
NEUROBEHAVIOURAL TESTING  
 Neurobehavioural testing is able to detect subtle or delayed effects 
of drugs administered during labour and delivery that are not appreciated 
by Apgar score. The testing evaluates neonate’s state of wakefulness, 
reflex (moro, rooting & sucking reflexes) response, muscle tone.  
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PHARMACOLOGY OF DRUGS 
Pharmacology of Bupivacaine  
 Bupivacaine is an amide linked local anesthetic. It is hydrochloride 
salt of d (1)-1 butyl 2’ 6’ pipecoloxylidide and is presented as a racemic 
mixture.  
 It was synthesized by BO of Ekenstem 
 First reports of its use were published in 1963 by Telivuo.  
 It is derived from mepivacaine and is a very stable compound and 
may be autoclaved repeatedly.  
pKa is 8.2    Partition co-efficient is 27.5 
Molecular weight is 288  Protein binding is 96% 
Availability  
Ampoules  : 0.5% bupivacaine hydrochloride 4 ml 
0.5% bupivacaine hydrochloride with dextrose (heavy) 4 ml 
Vials   : 0.25%, 0.5% bupivacaine hydrochloride20 ml. 
 
Dosage  
 Maximal dose  2 mg / kg body weight  
 Uses    Spinal  
    Epidural  
    Caudal  
    Continuous epidural  
    Peripheral nerve block  
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ONSET TIME AND DURATION OF ACTION 
Site of action  Onset (minutes) duration (minutes) 
Intrathecal  5 180-240 
Epidural  15-20 165-225 
Branchial plexus  15-20 600 
PHARMACOKINETICS  
 Once rejected intrathecally, it gets absorbed by the nerve rootlets 
and results in the desired effect. It is rapidly absorbed from the site of 
injection, but the rate of absorption depends on the vascularity at the site 
and presence of vasoconstrictors. High lipid solubility of bupivacaine 
makes it easy for nerve and vascular tissue penetration. 80-95% of the 
absorbed bupivacaine binds to the plasma protein. 
DISTRIBUTION  
Rapid distribution phase (α) 
 In this phase the drug is distributed to highly vascular region, t ½ α 
being 2.7 mts. 
Slow disappearance phase (β)  
 In this phase the drug distributes to slowly equilibrating tissues, t ½ β 
being 28 mts. 
Bio-transformation and excretion phase (δ) 
 t ½ δ is 3.5 hours. Clearance is 0.47 litres / minutes.  
Bio-transformation 
 It is by the liver. The N-dealkylated metabolite is pipecolyloxylidine.  
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Excretion  
 It is through the kidney.  
 4-10% of the drug is excreted unchanged in urine.  
Mode of Action  
a. Site of Action  
1. The spinal nerve rootlet-fine nerve filaments having a large 
surface area are exposed to the local anesthetic. 
2. Posterior and lateral aspects of the spinal cord itself.  
Sodium channel blockade  
 They impede sodium ion access to the axon-interior by occluding the 
transmembrane sodium channels thus denying the process of 
depolarization and axon remains polarized. It is a non-depolarization block.  
Pharmacodynamics  
 It has got a longer duration of action but a slower onset.  
Cardiovascular system  
 It reduces cardiac output by reducing the sympathetic tone, by 
slowing the heart and by reducing the venous return. It produces a fall in 
arterial blood pressure but it is relatively slow and is seldom very profound. 
It produces a fall in central venous pressure. It causes an increase in lower 
limb blood flow. It causes a reduction in incidence of deep vein thrombosis.  
Respiratory System  
 Spinal blockade seldom, if ever causes respiratory problems. 
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Gastro Intestinal Tract  
 There is an increase in gastro intestinal motility and emptying of 
gastric contents is better. 
Toxicity  
 Toxicity is related to plasma level of unbound drug and more likely 
due to an inadvertent intravenous injection. Systemic toxicity-reactions 
primarily involve central nervous system and cardio vascular system. The 
blood level required to produce central nervous system toxicity is less than 
that required to produce circulatory collapse.  
Central Nervous System Toxicity  
 Initial symptoms include feeling of light headedness and dizziness, 
followed by visual and auditory disturbances. Objective signs are excitatory 
and include shivering, muscle twitching and tremors. Ultimately generalized 
tonic, clonic seizures occur. 
CARDIO VASCULAR SYSTEM TOXICITY  
The rate of depolarization in fast conducting tissue of purkinjefibres 
and ventricular muscle is decreased. The rate of recovery of bupivacaine 
induced block is slower than that of lignocaine. Extremely high 
concentration of the drug causes sinus bradycardia and cardiac arrest.  
 Renantiomer is more toxic than S enantiomer. 
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Pharmacology of Fentanyl  
 Fentanyl is the only opioid available for various forms of 
administration. It can be used by the following routes. 
 Intramuscular  
 Intravenous  
 Neuraxial – Spinal, epidural administration for intra and 
postoperative analgesia. 
 Transdermal-applied before the induction of anaesthesia and left 
in place for 24 hours. It can reduce the amount of parental opioid 
requirements for post-operative analgesia.  
 Transmucosal – to decrease the anxiety and to facilitate induction 
of anaesthesia especially in children.  
 Dosage  
 Intramuscular  : 50-100μg (1-2 μg/kg) 
 Intravenous   : 50-100μg (1-2 μg/kg) 
 Intrathecal    : 10-25μg (0.25μg/kg -0.5μg/kg) 
 Epidural    : Bolusdose 1μg/kg 
 Continuous infusion : 30-100μg/hr.   
 after the bolus  
Onset time and duration of action  
Routes of administration Onset time (mins) Duration of action (hrs) 
Im 7-8 1-2 
Iv Immediate  0.5-1 
Epidural 10 2-3 
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Pharmacokinetics  
 Molecular weight   : 528 
 pKa    : 8.4 
 Plasma protein binding  : 84% 
 t ½ α    : 1-2 mins. 
 t ½ β    : 10-30 mins.  
 t ½ γ    : 2-4 mins.  
 Being a highly lipophilic opioid the vascular uptake and rapid 
circulation to brainstem is more and the rostral spread is of smaller 
magnitude. This kinetics of fentanyl is in contradiction to morphine and 
clinically produces rapid onset, shorter duration of action, early but not 
delayed respiratory depression. Once the fentanyl is systematically 
absorbed it is rapidly redistributed to inactive tissue sites such as fat and 
skeletal muscles with an associated decline in plasma concentration. The 
lungs also serve as a large inactive storage site, with an estimate 75% of 
the initial fentanyl dose undergoing first pass pulmonary uptake. Fentanyl 
is extensively metabolized by dealkylation, hydroxylation and amide 
hydrolysis to inactive metabolites, including norfentanyl and 
desprionylnorfentanyl that are excreted in the bile and urine.  
The pharmacokinetics of fentanyl can be described as three 
compartmental models with a distribution time of 1.7 minutes, redistribution 
of 13 minutes and a terminal half time of 219 minutes. The volume of 
distribution is 4 L/kg.Gastric acidity can ionize fentanyl and prevents its 
systematic absorption and once the acidity is neutralized, the systemic 
absorption can increase the plasma fentanyl concentration. Enterohepatic 
circulation of fentanyl can explain the delayed respiratory depression seen 
in some cases.  
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MODE OF ACTION 
Opioid Receptors  
 Mu, Kappa, Sigma, Delta and Epsilon are the opioid, receptors 
distributed in the supraspinal areas (periaqueductal grey matter, caudate, 
striatum and putamen) and the spinal cord (throughout the spinal gray 
matter with the highest density in the substantia gelatinosa).Fentanyl acts 
on the mu receptors in the supraspinal areas and on kappa and delta 
receptors in the spinal cord producing spinal analgesia.  
Intrathecally administered fentanyl gets attached to the spinal opioid 
receptors situated densely in the substantia gelatinosa and systemic 
absorption of the fentanyl can lead to supraspinal receptor binding and its 
effects. Investigations suggest that different receptors are existing for 
different opioids. These receptors are distributed throughout the CNS and 
other parts of brain like paleothalamic pathway, limbic system, medial 
thalamic, nuclei, periaqueductal grey matter, reticular formation, 
periventricular areas of medulla, substantia gelatinosa of spinal cord, 
lamina I & V of spinal cord. Opiate receptors are proteolipids which can 
bind to both agonists & antagonists.  
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Classification  
μ-receptor 
 Stimulation of this receptor causes supraspinal analgesia, euphoria, 
respiratory depression and physical dependence. This receptor is 
stereospecific and naloxone sensitive, Endogenous ligand for μ receptor is 
endorphin and exogenous ligand is morphine, the selective antagonist 
being naloxone.  
μ1-receptor    
 Stimulation of this receptor causes supraspinal analgesia and 
physical dependence. 
μ2-receptor    
 Stimulation of this receptor causes respiratory depression, inhibition 
of gastro intestinal tract motility and cardiovascular system effects.  
K-Receptor 
 Ketocyclozocine is the prototype agonist. Stimulation causes, spinal 
analgesia, sedation, miosis, physical dependence and inhibition of ADH 
secretion. Endogenous ligand is dynorphin and the selective antagonist is 
naloxone.  
δ-receptor    
 This receptor has high affinity for adrenocorticotrophic peptide 
hormone. Function is not clear but it may be responsible for modulation of 
activity of μ receptors. It may cause spinal analgesia and can cause 
respiratory depression it is not sterospecific and is naloxone insensitive. 
The protype agonist is d-Ala-d leuenkephalin. 
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α-receptors  
 Stimulation of this receptor causesdysphoria, hallucination, mydriasis 
and respiratory depression.  
ε-receptors  
 This receptor is not well characterized at present and it may be 
responsible for the stress response to pain. Endogenous ligand is β – 
endorphin and the antagonist being naloxone. Opioid receptors in the 
limbic system and hypothalamus are related to the emotional components 
of pain. Encephalin-containing receptors are found in Meissner’s plexus of 
duodenum, which probably affects gastro-intestinal motility. Opiate 
receptors are found in large numbers in the area postrema, which contains 
chemoreceptor trigger zone-the site where opiods are thought to induce 
nausea and vomiting.  
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Mechanism and site of action  
 Recent studies now point to the dorsal horn of spinal cord as the site 
of action of spinal opiate based upon ionatophoretic and micro-injection 
data. Radiolabelled morphine or fentanyl showed a strong focus of activity 
on the substantia gelatinosa. Opiate receptors are located both pre-
synaptically at the terminal of primary sensory afferents entering the dorsal 
horn and on the dentrites of post-synaptic membranes. Pre-synaptically, 
opiate peptides inhibit the release of substance-P, glutamate and other 
neurotransmitters like acetylcholine, noradrenaline, dopamine from sensory 
neurons.  
They also act post-synaptically by decreasing the excitatory, post-
synaptic potentials induced by persistent afferent stimulation. 
Intraoperative subarachnoid narcotics potentiate the antinociception 
provided by the local anesthetic agent.  
There is enhancement of comfort and also the visceral manipulations 
are better tolerated. Fentanyl also binds to M3muscarnic receptors in the 
heart leading to bradycardia which can be prevented by giving atrophine to 
the patient. Fentanyl also antagonizes 5 hydroxytryptaminelevel in the 
brain thereby potentiating the analgesic activity of other opioids.  
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PHARMACODYNAMICS OF FENTANYL 
Cardio Vascular System  
 It produces bradycardia by binding to M3 receptors. It slows AV node 
conduction and prolongs PR interval.  
Respiratory System  
 It can cause early respiratory depression. Peak effect is noted 5 to 
15 minutes following intravenous injection. Very rarely delayed respiratory 
depression can occur.  
Musculo Skeletal system  
 It may cause muscle rigidity, particularly involving the muscles of the 
chest wall. Skeletal muscle movements of various groups in the extremities 
of neck and extra ocular muscles have been reported during induction of 
anesthesia. This effect is related to the dose and speed of injection. 
Central Nervous System  
 It produces euphoria: sedation and miosis.  It will not interfere with 
evoked potential monitoring.  
Gastrointestinal Tract  
It causes nausea, vomiting and biliary spasm.  
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ADVERSE EFFECTS  
Respiratory Depression  
 Various studies have showed that respiratory depression may occur 
after any opioid irrespective of its route of administration.  
Urinary retention  
 It is likely to interact with opioid receptors located in sacral segments 
of spinal cord. This in turn promotes inhibition of sacral parasympathetic 
nervous system outflow which causes detrusor muscle relaxation and an 
increase in maximum bladder capacity leading to urinary retention. 
Pruritus  
 Most common side effect is pruritus. The incidence is 0-100%. It may 
be generalized or localized to the face, neck and upper thorax. The 
sensation appears around or just after the development of analgesia by 
epidural or intrathecal opioids.  
Nausea and Vomiting  
 Intraoperative incidence is 30%. It may be due to the cephalad 
migration of drug and subsequent interaction with opioid receptors in 
vascularized area postrema.  
Hypertension  
 Intrathecal pethidine and sufentanil cause hypotension whereas 
intrathecal fentanyl does not cause this effect. The mechanism is not 
known.  
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Delayed gastric emptying  
 This effect is mediated at the spinal level and hence neuraxial 
opioids are not exempt from this effect.  
Other effects  
 Chest wall rigidity  
 Apnoea 
 Bradycardia  
 Diaphoresis  
 Emesis  
 Dizziness  
 Blurred Vision  
Over dosage and treatment  
 The manifestations of fentanyl overdosage are an extension of its 
pharmacological actions.  
 Effects    Treatment  
 Hypoventilation   Oxygen therapy  
 Assisted or controlled ventilation  
 Severe respiratory  Naloxone  
 depression 
 Hypotension   Paraenteral fluid therapy  
 Pruritus    Chlorpheneramine 
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Clonidine 
Pharmacology of Clonidine  
 It is a 2, 6 – dichloro phenyl-4, 5 dihydro, 1H-imidazol-2, amine with 
formula C9H9Cl2N3. It is an imidazoline derivative and acts on both α1 and 
α2 receptors with ratio of α2 and α1 are 220:1. It stimulatesα2 receptors 
both at central and peripheral sites. It is not a pure α2 agonist and it also 
acts on non-adrenergic imidazoline preferring receptors. 
Availability  
 Ampoule – 1ml containing 150 μgm 
Various routes of administration and dosage  
Route  Dose  
Intra Nasal 2-4μg/kg 
Oral  4 – 5 μg/kg 
Intravenous  Bolus : 1-2μg/kg 
Infusion: 0.18-3.16μg 
Rectal  2.5-5 μg/kg with atropine 50μg/kg 
Caudal  1-2μg/kg 
Spinal adjuvant  1-2 μg/kg 
Epidural adjuvant  0.0625% bupivacaine with fentanyl     1 
μg/ml and clonidine 0.6μ/ml at a rate of 
0.2 ml/kg/hr.  
Sciatic nerve block 0.2% ropivacaine 0.4 mg/kg/hr with 
clonidine 0.12 μg/kg/hr as infusion  
Para verterbral block  19 ml bupivacine as a bolus with 
Clonidine 150 μg/kg given every 48 
hours for 3 weeks via catheter.  
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Pharmacokinetics  
Absorption  
 It is well absorbed by all the routes-oral, intravenous, intramuscular, 
transdermal etc. The bioavailability is nearly 100% by oral route. 
Elimination half-life of 6 to 12 hours with the mean of 12 hours, about half 
the drug administered is excreted unchanged through urine and the half-life 
of the drug is increased with renal failure.  
Metabolism  
Fifty percent of the drug is metabolized in the liver to inactive 
metabolites which are excreated in the urine.  
Drug Interactions  
 Tricyclic antidepresents and presumably phenothiazines and 
butyrophenone interfere with the action of Clonidine, but butyrophenone 
administration may produce hypertensive crisis at least theoretically, even 
though none has been reported. Acute Clonidine administration reduces 
anesthetic requirements by 40 to 60% chronic administration reduces by 
10 to 20%. 
Sub types of α2 receptors  
 1) α2A 2) α2B and  3) α2C 
 α2A - mediates sedation, sympatholysis, analgesia  
 α2B – vasoconstriction, anti-shivering mechanism  
 α2C–Sturtle response. It is the response of the body and minds to 
sudden unexpected stimuli e.g. a flash of light.  
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Mechanistic Information 
α2 receptors are located on primary afferent terminals (both 
peripheral and spinal endings) on neurons in superficial laminae of the 
spinal cord and within the brainsterm nuclei implicated in analgesia, 
supporting and possibility of analgesic action at periphery, spinal and 
brainsterm sites. Notably the axons of peripheral nerves or lacking the α2 
receptors, but Clonidine produces minor degree of conduction blockade at 
higher concentration with some preference to ‘C’ fibers.  
This action may underlie in part, in the enhancement of peripheral 
nerve block when this agent added to the local anesthetics. Analgesia 
produced by intrathecal Clonidine in not produced by systemic absorption 
because the peak levels in arterial blood is achieved within 10 minutes and 
in intravenous blood is within 30 to 45 minutes,Elimination from the blood is 
slow and the duration of analgesia is relatively brief and this point is 
contradicting against an action by systemic absorption and redistribution to 
central and peripheral site. 
Acetylcholine and Neuraxial Clonidine: 
 Epidurally administered Clonidine produces increase in release of 
acetylcholine in the dorsal horn of the spinal cord, but not in the ventral 
horn. Analgesia produced by the epidural Clonidine in volunteers is 
enhanced by the intrathecal injection of choline-esterase inhibitor 
neostigmine.  
This interaction is additive only in humans, but synergistic in animals. This 
supports the cholinergic mechanism in spinal analgesia produced by the 
Clonidine. The descending nor-adrenergic pathways release nor-
adrenaline to cause analgesia directly and by stimulating the release of 
acetylcholine. 
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Clonidine and local anesthetics 
 Clonidine enhances both sensory and motor blockade by three 
possible mechanisms.  
1. Clonidine blocks the conduction in the ‘C’ fibers and in the “Aδ” 
fibers, and increases the K+ion conductance in isolated neurons in-
vitro and it intensifies the conduction blockade produced by the local 
anesthetics, because the systemic pharmacokinetics are not the 
factor in vitro experiments. These data supports the direct effect of 
the Clonidine on neural transmission in high local concentration.  
 
2. Clonidine may produce vasoconstriction and thereby inhibiting the 
removal of the local anesthetics surrounding the neural tissues, but 
this occurs only in high concentrations and there is little evidence for 
this mechanism with clinically used concentrations and this is 
confirmed by the observation that the plasma lignocaine 
concentrations is same with or without Clonidine addition, but this 
plasma lignocaine concentrations is reduced because of decreased 
systemic absorption. 
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Pharmacodynamics effects:  
Action of the clonidine on myocardial performance  
1) Produces bradycardia partly due to vagomimetic action and partly 
due to pre-synaptically mediated inhibition of nor-adrenaline release 
at neuroreceptor junction. Although it depresses the AV nodal 
conduction, severe bradyarrythmias are rare with Clonidine.  
2) It increases the cardiac output by reducing the afterload, but in some 
patients, it reduces cardiac output due to the decrease in the heart 
rate.  
3) It reduces the Oxygen demand and has been shown to reduce the 
infarct size when administered to the patients in the acute phase of 
myocardial infarction. Haemodynamic effects after neuraxial  
administration starts within 30 minutes and reaches the maximum 
effect within 1 to 2 hours and lasts for approximately 6 to 8 hours 
after single injection. Delayed onset of hypotension has not been 
observed with the use of Clonidine for analgesia alone or in 
combination. 
 This combination produces higher degree of sympatholysis and the 
combination of Clonidine and local anesthetics in neuraxial route and 
resulting hypotension is also high. Clonidine has minor or no effects on 
responses to vasoconstrictors or atropine given to treat hypotension or 
bradycardia that may occur with neuraxial anaesthesia.  
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Clonidine pre-treatment delays the central nervous system or 
cardiovascular system toxic manifestations of Bupivacaine overdose and 
also it improves ventricular electrophysiologic parameters in dogs. But this 
is not to imply that Clonidine should be used as treatment for Bupivacaine 
overdose, but rather to emphasize that, should such overdose occur, 
inclusion of Clonidine is unlikely to exacerbate the problem. Spinal 
neostigmine counteracts the hypotension induced by Clonidine due to 
cholinergicallymediated increase in pre-ganglionic sympathetic neuron 
activity and it also enhances analgesia produced by Clonidine. This 
combination may be useful clinically. 
Sedation: 
 It commonly occurs after neuraxial administration of the Clonidine. 
After epidural administration, Clonidine by its systemic absorption and 
vascular redistribution to higher centers produces sedation. 
Site of Action  
 The brain stem nuclei called as locus ceruleus which is involved 
regulation of sleep, wakefulness. It is inhibited by P Protein mediated 
mechanism that involves inhibition of adenyl cyclase. 
Dose Dependent Sedation:  
Regardless of route administration the Clonidine produces rapid 
sedation in less than 20 minutes over the dose range of 50-900 μg. After a 
large epidural bolus dose (700 μg) sedation is intense for 4-6 hours and 
reduced the need for other sedatives, anxiolytics when Clonidine given 
intraoperatively. 
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Unique feature of sedation  
 The Clonidine produces arousable sedation but with other drugs 
which acting on GABA receptor it alsoproduces clouding of consciousness 
and causes paradoxical agitation. 
Respiratory Depression:  
 Although the respiratory depression produced by narcotics may be 
due to noradrenergic mechanism which is supported by some evidence. 
Clonidine alone does not induce respiratory depression even with massive 
dosesand it does not potentiate the depression produced by narcotics. 
Occasional reports of upper airway obstruction during deep sedation with 
Clonidine and which is accompanied by transient fall in oxygen saturation. 
So that monitoring the patients with pulse-oxymetry may be needed for 30 
minutes to 2 hours after large bolus doses.  
Hormonal effects:  
 As it is a potent sympatholytic agent, it reduces but not suppresses 
the stress hormones like nor-adrenaline, adrenaline, ACTH and cortisol. It 
promotes the release of growth hormone, but the effect is short lived. This 
also reduces the insulin release by direct action on islet cells, but it is 
clinically insignificant.   
Mechanism of Antishivering effect:  
 The clonidine synchronously decreases the cold-response threshold 
while slightly increasing the sweating threshold and thus suggesting that it 
acts on central thermal regulatory system rather than preventing shivering 
peripherally.  
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Urinary retention and Clonidine  
 Intrathecal opioids may produce urinary retention. Clonidine persedo 
not produce any urinary retention and it may actually hastens the time to 
first micturition after spinal anesthesia. 
Parasympathetic system and Clonidine  
 Clonidine produces bradycardia, AV nodal conduction delay.  
Vasoconstriction and anti-shivering mechanism is due to the direct action 
on postsynaptic α2 receptors present in the vascular smooth muscle.  
Uses  
1. It is used for pre-anesthetic medication  
2. It helps to reduce the stress response 
3. It helps to treat the withdrawal symptoms of alcohol, narcotics, and 
tobacco as it reduces the sympathetic manifestations of withdrawal 
syndrome.  
4. It is used to treat the post-menopausal hot flushes. 
5. It helps to differentiate the pheochromocytoma and hypertension. 
6. It helps to treat both intra-operative and postoperative shivering 
7. It helps to treat the postural hypotension as it has direct action on 
vascular smooth muscle. 
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Side Effects  
1. Excessive sedation in higher doses produces upper airway 
obstruction and decrease in oxygen saturation.  
2. Dryness of the mouth  
3. Contact dermatitis if it is used as a transdermal patch. 
4. Sexual dysfunction 
5. Abrupt-withdrawal in hypertensive patients leads to hypertensive 
crisis.  
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HISTORY AND REVIEW OF LITERATURE 
History  
Subarachnoid Block  
 In 1885, J. Leonard Corning, a New York neurologist first used 
cocaine experimentally dogs. In man, the first spinal anaesthesia was 
conducted by August Bier on 16.08.1898 with cocaine 3 ml as 0.5% 
solution. It was followed by Rudolf Matasin America and Tuffier in France.  
Bupivacaine  
 Bupivacaine was synthesized in Sweden by Ekenstam and his 
colleagues in 1957 and used clinically by L.J. Telivuo in 1963. 
Intrathecal Opioids  
 Gate control theory of pain (1965) by Melzack and Wall focused the 
attention on importance of dorsal horn of spinal cord in the modulation of 
pain. In 1973, Pert &Sndyer identified the specific opiate receptors in the 
substancia gelatinosa of dorsal horn of spinal cord. In 1976, spinal effects 
of intrathecal opiates in animals were demonstrated by Yaksh& Rudy. In 
1977, Wang, Naurs& Thomas studied the effect of intrathecal morphine in 
men in intractable pain of lower limb due to malignancies invading 
lumbosacral plexus.  
 In 1980, Davier et al, identified that respiratory depression with 
intrathecal morphine was reversed with systemic naloxone, without 
reversing analgesia. In 1981, Yaksh& Rudy described the action of 
intrathecal pethidine and morphine in primates by ionotophoretic 
administration of the drugs into the substantia gelatinosa.  
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They found out high level of opiate binding in substantia gelatinosa 
indicating the presynaptic action of opiate. Spinal opiates also seemed to 
cause significant elevation of nociceptive threshold.  
 In 1984, Huang HJ, Ishimain T, Yambe studied the use of intrathecal 
morphine for postoperative pain relief. In 1988, Inagaki Y, Takeyama E 
studied the efficacy of postoperative pain relief after the use of intrathecal 
buprenorphine with local anesthetic agent and found it to prolong the 
postoperative analgesia.  
Intrathecal Clonidine 
 Bonnet et al., studied that spinal Clonidine as an adjuvant with 
Bupivacaine in orthopedic surgeries and proved that the combination was 
effective in preventing the tourniquet pain and effectively prolonging the 
post-op analgesia. 
Fogarty et al compared Clonidine vs. morphine with Bupivacaine in 
patients undergoing total hip replacement surgeries. Intrathecal Clonidine 
prolonged the duration of spinal analgesia, but was markedly inferior to the 
intrathecal morphine in providing subsequent postoperative analgesia.  
Grace et al studied the co administration of Pethidine with Clonidine 
in spinal anaesthesia for total hip replacement surgeries.  
Monica brunschwiller et al compared intraoperative anesthetic and 
haemodynamic effects of clonidine-bupivacaine, morphine-bupivacaine 
and placebo-bupivacaine combinations during continuous spinal 
anaesthesia in knee replacement surgeries and concluded that 0.15 mcg 
Clonidine but not 0.15 mg morphine prolonged surgical analgesia when 
added to 10 mg plain Bupivacaine.  
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Pan etal studied the analgesic effects of intrathecal neostigiminevs. 
Clonidine with Bupivacaine in cesarean section. Their study showed that 
the combination of 150 μg Clonidine and 50μg neostigmine provided longer 
post-surgical analgesia than with either drug used alone. However, this 
combination also produced significantly more adverse effects of prolonged 
motor blockade nauseaand vomiting.  
Philip.J.Siddall et al studied that the efficacy of intrathecal Morphine 
and Clonidine in the treatment of pain after spinal cord injury. They 
demonstrated that administration of a combination of morphine and 
Clonidine into the spinal fluid can provide substantial pain relief in some 
people with this type of pain.  
Spinal Opioids and Labor analgesia  
 Opiates have been used as analgesic agents in obstetrics since the 
Babylonions discovered their pain relieving properties. Subarachnoid block 
was first used for obstetric delivery in 1901 by Kresis in Germany. 
 Intrathecal pethidine in labour and delivery was reported in-British 
Journal of Anaesthesia in 1987.Morphine was the first opioid to be used 
intrathecally but has limitations of long latency, high incidence of maternal 
side effects, poor perineal analgesia (Alper M, Intrathecal morphine; a new 
method of obstetric analgesia, Anaesthesiology, 1979: 51:378-379). 
Fentanyl and Intrathecal anaesthesia  
 The increased availability of lipid soluble with shorter latency and 
demonstration of synergistic effect of opioids when combined with local 
anesthetic have led to the widespread use of neuraxial opioids in labour. 
The effect of lipophilic agents are better when administered at the level at 
which analgesia is required. Commonly used opioids are meperidine, 
fentanyl and sufentanil.  
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(Honet JE, Arkoosh VA, Norris MC et al., comparison among intrathecal 
fentanyl, meperidine and sufentanyl for labour analgesia Anae Anal 1992; 
75:734-739). 
 Justins et al., 1982: The doses of local anesthetic required for labour 
pain relief can be diminished to one half to one thirds with the addition of 
intrathecal opioids and provide excellent analgesia for the entirety of 
labour. Mok et al, 1984; Intrathecal injection of fentanyl, sufentanil, 
alfentanil and nalbuphine have been reported for post-operative analgesia 
with promising results.  
 Belzarene, Sergio D. et al 1990: The clinical effects of fentanyl 
administered into the subarachnoid space were assessed in 120 
caesarean sections with spinal anaesthesia using 0.5% hyperbaric 
bupivacaine. They concluded that regression of anaesthesia to the T12 
dermatome took a longer time as the dose of fentanyl was increased.  
Neonatal status was not depressed  
 Wang, Chen MB et al., 1993: This study examined the effects of 
bupicacaine administered intrathecally on sympathetic efferent and ‘A-
Delta’ and ‘C’ fibre-mediated afferent pathways in dogs and the interactions 
with intrathecal fentanyl. The results showed that intrathecal bupicacaine 
has not selectivity for the afferent and efferent pathways and intrathecal 
fentanyl acts synergistically to enhance the effect of bupivacaine on the 
afferent pathway without a measurable effect on sympathetic outflow.  
 Singh, Harbhej, Yang et al 1995; they studied the effect of intrathecal 
fentanyl on the onset and duration of hyperbaric bupivacaine-induced 
spinal block in adult male patients undergoing genitourinary surgery. They 
concluded that fentanyl 25μg, prolonged the duration of bupivacaine-
induced sensory block (sensory regression to L1 dermatome) by 28% and 
increased the postoperative analgesia. 
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 Hunt et al, reported that the addition of fentanyl 6.5μg to hyperbaric 
bupivacaine reduced the intraoperative opioid requirement in patients 
undergoing caesarean delivery under spinal block. Belzarena et al 
demonstrated that low dose fentanyl 0.25μg/kg with bupivacaine 0.5% 
provided excellent surgical anaesthesia with few side effects. An increased 
dose of fentanyl to 0.5μg/kg was associated with an increased incidence of 
adverse effects in patients undergoing caesarean delivery. Palmer CM et 
al., 1995: 15μg of fentanyl was added as a sole adjuvant to hyperbaric 
lidocaine in spinal anaesthesia in parturients undergoing caesarean 
delivery and concluded that the addition of fentanyl increases the duration 
of effective analgesia by approximately 30 minutes and provides a 
protective effect regarding nausea and vomiting in the post operative 
period.  
 Dahigren, Gunnar et al 1997, compared the effects of intrathecal 
sufentanil 2.5 and 5 mg, fentanyl, 10μg, and placebo when administered 
together with hyperbaric bupivacaine 0.5%, 12.5 mg for caesarean section. 
This demonstrated that small doses of fentanyl or sufentanil (Synthetic 
opioids) added to bupivacaine (local anesthetic) for spinal anesthesia for 
caesarean section reduce the need for intraoperative antiemetic 
medication and increase the duration of analgesia in the early 
postoperative period compared with placebo.  
 Ce-Ben David et al 1997: by exploring the synergism between 
intrathecal opioids and local anesthetics, it may be possible to augment the 
spinal anaesthesia without prolonging the recovery. Based on this fact, 
they have done the study on 50 patients undergoing ambulatory surgical 
arthroscopy. Implications; Small dose bupivacaine is inadequate for this 
procedure, but the addition of fentanyl makes it reliable.  
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Cang FC, Tsai FC et al 1998: Neuraxial opioid may augment the analgesia 
produced by local anesthetic through direct binding with the spinal opioid 
receptors. Theoretically, the reduction of local anesthetic by addition of 
fentanyl would provide better haemodynamic stability and good anesthetic 
status. They conducted the study in 30 healthy parurientsundergoing 
caesarean section They concluded that the combination of small-dose 
bupivacaine with fentanyl could provide more stable haemodynamic status, 
longer post operative analgesia and lower incidence of shivering. The 
incidence of pruritus was higher but usually mild.  
 Roussel JR et al, 1999: The have conducted a study on the effects 
of intrathecal fentanyl on duration of bupivacaine spinal blockade for 
outpatient knee arthroscopy and concluded that fentanyl does not enhance 
the onset and duration of sensory or motor block produced by intrathecal 
bupivacaine. Fentanyl however prolongs post operative analgesia and 
increases the risk of pruritus.  
 Sarvela PJ et al 1999: They compared the effect of 9 mg of 
intrathecal plain and hyperbaric bupivacaine-both with fentanyl-for 
caesarean delivery. 
 They concluded that either plain or hyperbaric bupivacaine with 
fentanyl intrathecally provided similar onset, depth and duration of sensory 
anesthesia to caesarean delivery with good maternal satisfaction.  
 Choi DH, Ahn 2000: The study was performed on 120 patients for 
caesarean delivery. They hypothesized that the addition of fentanyl could 
reduce the dose of bupivacaine necessary to achieve adequate surgical 
anaesthesia.  
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They concluded that the optimal dose of hyperbaric bupivacaine to produce 
surgical anaesthesia was 12 mg, which was accompanied by high sensory 
block. With the addition of 10μg of fentanyl, the dose of bupivacaine could 
be reduced to 8 mg in spinal anaesthesia for caesarean delivery.  
 Ben-David B, Frankel R et al, 2000: They student the effect of mini 
dose bupivacaine-fentanyl spinal anaesthesia for surgical repair of hip 
fracture in the aged.  
 The synergism between intrathecal opioid and local anesthetics may 
make it possible to achieve reliable spinal anaesthesia for surgical repair of 
hip fracture in the aged.  
 The synergism between intrathecal opioids and local anesthetics 
may make it possible to achieve reliable spinal anaesthesia with minimal 
hypotension using a small dose of local anesthetic.  
 20 patients for more than 70 years of age for surgical repair of hip 
were divided into 10 patients of 2 groups each.  
 Group A, received bupivacaine 4 mg + fentanyl 20μgGroup B, 
received 10 mg bupivacaine  
 They concluded that the mini dose combination caused dramatically 
less hypotension than 10 mg bupivacaine and nearly eliminated the need 
for vasopressor support of blood pressure.  
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Clonidine and Intrathecal Anesthesia 
Dekock.M. et.al, studied spinal clonidine with ropivacaine in 
ambulatory knee anthroscopy surgeries. They concluded that small-dose 
intrathecal clonidine (15μg) plus 8 mg intrathecal ropivacaine produces 
adequate and short-lasting anaesthesia for knee-arthroscopy.  
Debrydnjov I et al, have tried 6 mg of 0.5% heavy Bupivacaine with 
15μg Vs. 30μg of Clonidine for unilateral spinal anaesthesia in unilateral 
inguinal hernia surgeries and showed it have produced excellent post-op 
analgesia. The concluded that use of Clonidine as adjuvant to small dose 6 
mg Bupicacaine for ambulatory inguinal herniorraphy.  
Michael .J. Peach et. al., (10 (2004) anaes.analg., 2004: 95:56-59) –
studied intrathecal fentanyl with morphine and varying doses of Clonidine 
in cesarean surgeries for post-op analgesia. A multimodal approach to 
post-cesarean analgesia, using subarachnoid Bupivcaine, fentanyl, 
morphine 100μg, and Clonidine 60μg, improves pain relief compared with 
morphine 100μg or Clonidine 150μg alone, but increases intra-operative 
sedation and may increase peri-operative vomiting.  
Alain Rochette et al studied spinal Clonidine in neonates. Spinal 
anesthesia is suitable but often too short for complete surgery in newborns. 
This controlled, randomized, prospective, dose-ranging study was 
conducted in 75 neonates to test the hypothesis that Clonidine could 
significantly lengthen Bupivacaine spinal block. He concluded that 
Clonidine 1 μg/kg, added to spinal isobaric Bupivacaine, doubles the 
duration of the block without significant deleterious hemodynamic or 
respiratory side effects.  
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Van Tuiji et  al (12. (2006) Br. J. An. 97(3); 365-70) have studied the 
addition of intrathecal clonidine to hyperbaric Bupivacaine on post-op pain 
and morphine requirements after cesarean section. They concluded that 
addition of 75μg Clonidine to hyperbaric Bupivacaine 2.2 ml prolongs 
spinal analgesia and motor block after cesarean section and improves 
early analgesia without any clinically relevant maternal or neonatal side 
effects.  
B.S. Senthil, et al., (13 (2007), I.J.A), have studied the efficacy of low 
dose intrathecal Clonidine as adjuvant to bupivacaine in gynecological 
surgeries. They have added 1 μg/kg of Clonidine with 2.5 ml of 
Bupivacaine Vs. plain Bupivacaine. They concluded that by adding 
clonidine, the postop analgesia is significantly prolonged with an effect on 
sedation, heart rate and MAP which does not require any therapeutic 
intervention.  
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MATERIALS AND METHODS 
 Following approval by the institutions ethical committee, this 
prospective study was done at Tirunelveli Medical College Hospital, 
Tirunelveli in 120 patients undergoing elective or emergency caesarean 
section after getting informed consent from each patient and explaining the 
procedure. This is a randomized prospective comparative study.  
Inclusion Exclusion Criteria  
 Term, parturient, ASA I an ASA IE who were fit to undergo spinal 
anaesthesia for caesarean section, age between 18-35 yrs., are selected. 
Patients with medical and obstetrical complications and impaired placental 
function were excluded; patients who were converted to general 
Anaesthesia were also excluded from the study.  
Preoperative Preparation  
 Preoperatively all patients were seen by the anesthetist. The 
procedure was explained in detail and informed consent was obtained. No 
premedication was given. Patients were randomly allocated into 3 groups 
of 40 each.  
A- Control Group - Injection (0.5%) Bupivacaine 1.8 ml + 
0.4 ml NS 
B- Study group 1 inj. (0.5%) Bupivacaine 1.8 ml + 
Clonidine 30 μg) + 0.2 ml NS. 
C- Study group 2 Inj (0.5%) Bupivacaine 1.8 ml + Clonidine 
(30 μg) +fentanyl (10μg)   
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Procedure  
 On arrival to operation theatre, basic monitoring was applied to all 
patients and basic pulse rate, blood pressure, oxygen saturation 
and respiratory rate were recorded.  
 Intravenous line with 18 g canula was established and preload of 
250-300 ml of crystalloid was given to all patients.  
 Following resuscitative measures were kept ready before the start 
of the procedure: Boyles machine with oxygen source, 
laryngoscope and appropriate size blades, suction apparatus, 
vasopressors (Ephedrine), naloxone and other emergency drugs.  
 The subarachnoid block was performed in right lateral position 
with 23 G spinal needle through L3, 4 space. Free flow of CSF 
was ensured before introducing the drug. The drug injected was 
according to the group assigned.  
 A- Injection (0.5%) Bupivacaine 1.8 ml + 0.4 ml NS 
B-       inj. (0.5%) Bupivacaine 1.8 ml + Clonidine 30 μg) + 0.2 ml NS. 
C-Inj (0.5%) Bupivacaine 1.8 ml + Clonidine (30 μg) + fentanyl 
(10μg) 
Drugs were measured in a sterile tuberculin syringe. Thorough aseptic 
precautions were taken during the addition of injection and making the final 
injection. 
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Immediately after the intrathecal injection the patients were gently turned to 
supine position with leftward tilt by a wedge under right buttock 100% 
oxygen was given through Magills breathing system till the delivery of 
baby. 
Assessment of Patient and Recording of Data 
 Time of subarachnoid block was noted.  
Following observations were made  
1. Time of onset of analgesia  
2. Time of maximum cephalic spread 
3. Upper level of sensory block. 
4. Grade of motor block obtained according to bromage motor 
scale.  
Bromage motor scale  
0- No paralysis  
1- Inability to raise extended legs. 
2- Inability to flex the knee joint 
3- inability to flex the ankle joint  
 After the establishment of an adequate level of analgesia, the 
surgeons were allowed to operate and the time of beginning of surgery was 
noted.  
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Blood pressure, pulse rate, respiratory rate and Spo2 were monitored 
intraoperatively every 2 minutes for the first 10 minutes and every 5 
minutes till the end of surgery. Patients were watched for side effects like 
hypotension, bradycardia, and vomiting, itching and respiratory depression.  
 Any hypotension (30 % fall from base line) was treated with oxygen, 
intravenous fluid and inj. ephedrine. Any bradycardia (pulse rate <60 mt) 
was treated with inj. atropine  
Nausea and vomiting were treated with inj. metaclopromide 
Pruritis if complained was treated with inj. chlorpheniramine maleate.  
Two segment regression time  
 Time to decrease from maximum sensory level to 2 segments below 
that level was noted.  
Sedation state was assessed by  
Brain and Ready sedation score 
1. Awake and alert 
2. Drowsy  
3. Sleepy but easily arousable on call. 
4. Sleepy but difficult to arouse. 
In the postoperative period, any complications to the mother and 
baby, especially that is attributed to opioids like respiratory depression, 
nausea, vomiting, pruritus were noted (one of the expected complication 
i.e., urinary retention could not be studied as all the patients were 
invariably catheterized).  
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Total duration of analgesia was taken as the period from the time of 
giving subarachnoid block till the patient’s first requirement of analgesic 
medication. Pain was evaluated using 10 cm linear visual analogue scale 
(VAS) with 0 for no pain and 10 for worst pain. If VAS was more than 6, 
supplementary analgesia was given and the study was assumed to be 
concluded at that point. 
Foetal Outcome  
 Immediately after delivery, foetalwell being was assessed by 1 mt. 
and 5 mt. Apgar score. During the postoperative period, the well being of 
the baby whether exclusively sedated or not and the nature of cry were 
noted. 
 Reflexes like sucking reflex, rooting reflex and moro reflex were 
tested. Presence of seizures, if any, was also noted. All mothers and their 
babies were followed up till their discharge.  
Statistical Method 
Results were expressed as mean ± standard deviation. Statistical 
significance was determined by Anova table.  
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OBSERVATIONS AND RESULTS  
 
Statistical Analysis: 
  
The Randomization of three groups was done by matching  
their age, height,  and weight of their demographic factors and base 
Physiological factors such as pulse rate,  SBP, respiration rate and 
SPO2 by ANOVA (Analysis of  Variance). The differences between 
them were interpreted by the Post hoc test of Bonferroni. Similarly, 
the time for maximum loss of sensation, the 2 segment regression 
time, pain free time and Apgar score at 1 minute and 5 minutes were 
compared between groups by ANOVA.  
 
The intra and post-operative pulse rate and SBP at different 
intervals were compared between groups by ANOVA and interpreted 
the difference by Post hoc test of Bonferroni.The sensation level and 
sedation score were analyzed and interpreted by χ2 test (Chi- square). 
The above statistical procedures were performed by the statistical 
package IBM SPSS statistics 20. The P - values less than 0.05 
(P<0.05) were treated as significant in two tail condition.  
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Results  
Randomization by group matching: 
 The three groups were namely A (Bupivacaine only), B 
(Bupivacaine + intrathecal clonidine) and C (Bupivacaine + intrathecal 
fentanyl + Clonidine). Each group 40 Caesarean Sections were 
selected and data were collected before during and after surgery. For 
Randomization the three groups were matched according to their 
selected and related demographic characteristics and base level 
Physiological characteristics. 
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Table-1. Matching of three groups according to their 
demographic characteristics 
Variables 
Group 
N Mean S D ANOVA 
’F’ 
Df Significance 
Age 
A 40 24.6 4.4    
B 240 24.1 3.6 1.092 2,117 P>0.05 
C 340 25.4 3.8    
Weight 
A 40 58.5 5.0  2,117 P>0.05 
B 240 59.4 8.3 0.319   
C 340 59.6 7.2    
Height 
A 40 155.8 6.1    
B 240 154.2 4.2 2.021 2,117 P>0.05 
C 340 156.8 6.4    
 
The three groups were matched in respect of their age, weight and 
height and shown in the table -1. They were not significantly differed 
between them (P>0.05). 
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Table - 2 matching of three groups according to their 
Physiological characteristics 
Variable Group n Mean SD ANOVA 
‘F’ 
Df Significance 
Base PR 
A 40 85.2 5.8  
1.466 
 
 
2,117 
 
 
P>0.05 
 
B 40 87.3 7.2 
C 40 85.2 5.9 
Base 
SBP 
A 40 121.5 9.6  
0.015 
 
 
2,117 
 
 
P>0.05 
 
B 40 121.6 10.2 
C 40 121.2 7.9 
Base RR 
A 40 18.4 1.0  
2.831 
 
 
2,117 
 
 
P>0.05 
 
B 40 19.0 1.0 
C 40 18.6 0.9 
Base 
SPO2 
A 40 97.2 0.9  
3.748 
 
 
2,117 
 
 
P>0.05 
B 40 96.9 1.0 
C 40 96.6 0.8 
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The Physiological characteristics of three groups were matched 
and stated in the above table -2. There was no significant differences 
were observed between groups in respect of their base Physiological 
characteristics (P>0.05). 
 
Maximum Sensory level, Time and 2 Segment regression time:  
 
 The maximum sensory level and maximum time taken to reach 
the level were compared between three groups. The 2 segment 
regression time was also compared between the three groups. 
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Table-3 Comparison of sensory level between three groups. 
Max 
Sensory 
level 
GROUPS 
χ2 df Significance 
A B C Total 
T4 1 2 10 13 
76.795 8 P<0.001 
T 5. 3 13 21 37 
T 6. 14 25 9 48 
T 7. 19 0 0 19 
T 8. 3 0 0 3 
  
The above table -3 associates the maximum sensory level of three 
groups. 
The group A was associated with T7, B was associated with T6 
and C was associated with T5. The above associations were 
statistically very highly significant (P<0.001). 
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Table-4 Duration of time (minutes) to attain Sensory blockade or 
level between groups. 
Group
s 
n Mean SD ANOVA 
‘F’ 
d.f Signific
ance 
Significantly 
differed groups 
A 40 3.8 0.8 
8.003 
 
2,117 
 
P<0.01 
C differed with B 
and not differed 
with A. A&B not 
differed. 
B 40 3.6 0.7 
C 40 4.3 0.8 
  
The sensory time between the groups were compared in the table-4. 
The mean time of A was 3.8±0.8 minutes with mean time of B 
(3.6±0.7) and C (4.3±0.8) not differed significantly (P>0.05). But the 
means of B (3.6±0.7) and C (4.3±0.8) were differed significantly 
(P<0.01). 
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Table - 5 two segment regression time (minutes) to attain 
Sensory level between groups. 
 
Group
s 
n Mean SD ANOVA 
‘F’ 
d.f Significan
ce 
Significantly 
differed groups 
A 40 69.4 8.6  
177.952 
 
 
3,117 
 
 
P<0.001 
 
A,B&C were 
differed 
significantly 
between 
Them. 
B 40 89.5 5.7 
C 40 101.1 8.1 
 
The two segment regression time between the groups were 
compared in the above table 5. The means of three groups were 
differed significantly between them (P<0.001). 
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Table-6 Comparison of pulse rates between groups at different 
intervals. 
Interval Group n 
Mean SD
ANOVA 
‘F’ 
df Significance Significantly 
differed 
groups 
5 Min 
A 40 88.2 7.6  
4.370 
 
 
3,117
 
 
P<0.01 
 
A vs. B 
Significant 
AvsC, and  
BvsC not 
significant 
B 40 93.5 9.1
C 40 90.6 7.5
15 Min 
A 40 92.5 9.1  
2.107 
 
 
3,117
 
 
P>0.05 
 
A,B & C were 
not significant B 40 95.5 8.5
C 40 91.8 8.3
30 Min 
A 40 91.2 6.7  
5.012 
 
 
3,117
 
 
P<0.01 
 
A vs. B Not 
Signify 
B vs. C 
significant 
A vs. C Not 
Signify 
B 40 94.2 7.6
C 40 89.4 6.1
  
The above table -6 shows the pulse rate at different intervals 
like at 5 minutes 15 minutes and 30 minutes. The group A was 
significantly differed with group B (P<0.05) and C was not significantly 
differed with groups A and C (P>0.05) at 5 minutes. At 15 minutes no 
significant difference was observed between the three groups 
(P>0.05). At 30 minutes B significantly differed with C (P<0.01) and at 
the same time A&B and A&C were not significantly differed (P>0.05). 
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Table-7 Comparison of SBP between groups at different 
intervals. 
Interval Group n 
Mean SD 
ANOVA 
‘F’ 
df Significance Significantly 
differed 
groups 
5 Min 
A 40 120.6 11.4  
2.136 
 
 
3,117
 
 
P>0.05 
 
Three 
groups were 
not differed 
significantly 
B 40 116.2 13.5
C 40 120.9 8.8 
15 Min 
A 40 102.4 12.4  
14.357 
 
 
3,117
 
 
P<0.001 
 
Significant. 
differed with 
B & C. but B 
& C not 
differed.  
B 40 115.8 9.9 
C 40 112.2 12.0
30 Min 
A 40 105.9 12.5 7.838 
 
3,117
 
P<0.01 
 
A&B differed 
Sig. 
A&C and 
B&C not 
differed. 
B 40 115.1 9.7 
C 40 110.8 8.4 
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The SBP at different interval between the groups were shown in 
the above table-7. At 5 minutes, three groups were not significantly 
differed between them (P>0.05). At 15 minutes A significantly differed 
with the groups B and C (P<0.001). But B&C was not significantly 
differed between them (P>0.05). At 30 minutes A&B differed 
significantly (P<0.05). But A vs C and Bvs. C were not significantly 
differed (P>0.05). 
 
Pain free time (minutes): 
 The pain free, the duration of time with out pain was analyzed 
between the three groups to identify in which group the pain was 
lasting. 
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Table-8 Comparison of pain free time (minutes) between the 
groups. 
Groups n Mean SD ANOVA 
‘F’ 
d.f Significan
ce 
Significantly 
differed groups 
A 40 125.8 23.1  
177.955 
 
 
3,117 
 
 
P<0.001 
 
All were differed 
significantly 
between them 
B 40 178.2 14.4 
C 40 221.6 28.4 
 
The pain free time between the groups were compared in the 
above table 8. The means of three groups were 125.8±23.1, 
178.2±14.4 and 221.6±28.4 respectively. They were significantly 
differed between them (P<0.001). 
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Table-9 Comparison of sedation between three groups. 
 
Sedation 
level 
GROUPS 
χ2 Df Significance 
A B C Total 
0 17 2 0 19 
96.092 6 P<0.001 
1 23 28 3 54 
2. 0 10 29 39 
3 0 0 8 8 
Total 40 40 40 120 
 
The sedation levels of three groups were associated in the 
above table-9. The sedation level 1 was associated with groups A 
and B. The sedation level 2 was associated with group C. The above 
associations were statistically very highly significant (P<0.001). 
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Table 10 Comparison of Apgar scores at 1 minute and 5minutes. 
Time Groups n Mean SD 
ANOVA 
‘F’ 
Df Significance 
Significantly 
differed 
groups 
1 
Min 
A 40 7.6 0.5 
0.122 3,117 P>0.05 
All were not 
significant B 40 7.5 0.6 
C 40 7.5 0.7 
5 
Min 
A 40 9.1 0.5 
4.790 3,117 P<0.05 
A & B only 
significant. 
Others NS 
B 40 8.8 0.5 
C 40 9.0 0.3 
 
 The Apgar score at 1 minute and 5 minutes were compared 
between the three groups in table 10. At 1 minute the Apgar were not 
significant between groups (P>0.05). At the Apgar scores of groups 
A&B was significantly differed (P<0.05). The others A&C and B&C 
were not statistically significant (P>0.05). 
 
Inter-operative Complications  
Nausea and vomiting occurred in 7.5% of all three groups. All were 
treated with inj. Metaclopromide.  
Pruitus developed in only one patient i.e. 2.5% of group A patients.  
 In group B, 7.5% of patients developed pruitus.  
 In group C, 12.5% of patients developed pruritus  
 All were treated with inj. Chlorpheniramine maleate.  
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Post-Operative Complications  
 Nausea and vomiting occurred in 5% of patients in group A and 
group B and 2.5% in group C and they were treated with inj. 
Metaclopromide. 
 Pruritus occurred in 2.5% of patients in group B and 7.5% of 
patients in group C and they were treated with inj.chlorpheniramine 
maleate.  
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DISCUSSIONS: 
 
 For Randomization, the three groups were matched with their 
age, height, weight, pulse, SBP, respiration and SPO2 and found that 
there was no significant difference between them (P>0.05). Hence, 
there groups were comparable groups.  The sensory level T4 was 
obtained by A group 1(2.5%), B group 2(5%) and C group 10 (25%). 
The above attainment by C group was significantly greater than the 
other A& B groups (P<0.001). The mean time of C was significantly 
greater than B (4.3±0.8 > 3.6±0.7) and A and C were equal (4.3±0.8 = 
3.8±0.8). The two segment regression time for C group was 
significantly more than B and the same for B was significantly more 
than A.(101.1±8.1 > 89.5 ± 5.7 > 69.4 ±8.6  and P<0.001). 
  
The Pulse rate at 5 minutes of B group was significantly greater 
than A and C groups. (93.5 ±7.6 > 88.2±7.6 &90.6 ±7.5) and A group 
C group was equal (88.2±7.6 = 90.6 ±7.5). At 15 minutes, the pulse 
rates of three groups were more or less equal. (92.5±9.1 = 95.5±8.5 = 
91.8=8.3 and P>0.05). At 30 minutes the pulse rate of C group was 
lesser than B group (89.4 ±6.1<94.2 ±7.6 and P<.0.01). 
The same of A vs. B and A vs. C were more or less equal (91.2±6.7 = 
94.2 ±7.6 and 91.2 ±6.7 = 89.4±6.1 and P>0.05). 
  
The SBP at 5 minutes of three groups were 120.6 ±11.4, 116.2 
±13.5 and 120.9 ± 8.8 minutes respectively. The means were not 
significantly differed (P>0.05). At 15 minutes, the mean SBP of A 
group was 102.4 ± 12.4 and the same was significantly lower than B 
and C groups (102.4 ± 12.4 < 115.8 ± 9.9 & 112.2 ±12.0 and P<0.01). 
At 30 minutes, the mean SBP of B group was significantly higher than 
72 
 
B group (115.1± 9.7 > 105.9 ±12.5 and P<0.01).  The mean SBP of A 
vs. C and B vs. C were not significant (P>0.05).  
  
The pain free time of C group was significantly greater than B 
group and B group was significantly greater than A group (221.6 
±25.4 >178.2±14.4 >125.8±23.1and P<0.001). 
  
The sedation level of A (57.5%) and B (70%) groups was 
associated with level 1 and C (72.5%) was associated with level 2. 
The improvement was very highly significant (P<0.001). 
  
The Apgar score between the three groups was not significant 
at 1 Minute, But at 5 minutes, A group was significantly improved than 
B (9.1±0.5 > 8.8 ±0.5 and P<0.05). The A vs. C (9.1±0.5 = 9.0±0.3) 
and B vs.C (8.8 ±0.5= 9.0±0.3) were not significant (P>0.05). 
  
From the above results and discussions the C group administration is 
better than the above two groups namely A and B groups. 
• Evidences to conclude, improved quality of analgesia is the 
post-operative period (Paech M. J. et al). 
• There is not of much difference in the onset of analgesia, 
similar to studies by Singh Harbhej et al. 
• Two segment regression took longer time (C>B>A), similar to 
study conducted by Belzarena Sergio et al. 
• Duration of analgesia increased (C>B>A), consistent with 
cong FC et al. 
Hemodynamics  
• There is less incidence of hypotension and Bradycardia, 
consistent with studies by Cang Fc, Chang PG et al. 
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Complications  
• No respiratory depression occurred in any of these patients, 
consistent with study conducted by Lan et al. 
• Pruritus developed in 12.5% in Group C, consistent with the 
study conducted by Cang Fc, Tsai YC et al. 
Fetal Outcome  
 Low dose opiods do not have adverse effects on fetus and 
neonates (Ohen S, Arn et al) (Fernado F, Bonello E et al).  
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Conclusion  
 The above study bears out the following facts. 
1. Intrathecal clonidine and the clonidine fentanyl combination, 
both improved quality of Intra Operative analgesia. 
2.  Combination of clonidine with fentanyl increased the intra 
operative analgesic efficacy and significantly prolonged post-
operative analgesia compared with clonidine alone.  
3. Stable Intra Operative hemodynamics was obtained.  
4. Duration of analgesia was prolonged. 
5. The incidence of side effects due to additive effects of the 
drugs was minimal.  
6. Fetal outcome was not altered.  
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COMPARATIVE EVALUATION OF ADDITION OF INTRATHECAL FENTANYL AND 
CLONIDINE ADDED TO 0.5% HYPERBARIC BUPIVACAINE FOR LOWER 
SEGMENT CAESAREAN SECTION 
 
PROFORMA 
CASE NO: 
 
Name:       Age:      IP No:      Date: 
 
Address:      Unit:      Wt:      Ht: 
 
ASA:        Surgeon:    Anaesthetist:               Assessment 
No: 
 
PRE OP STATUS 
Inves 
Hb:        B Urea:     
        B Sugar: 
        S creatinine:       
PR:        Bp:      Cvs:      Rs: 
 
PRE MEDICATION 
Pre loading: Yes/No    Type of fluid:          Amount given 
 
Position for SAB:    Level of Inj.    Time of Inj.    Drug &Dose 
given: 
 
PARAMETERS STUDIED 
 
Time of onset of sensory block and level –  
 
Grade of motor block – 
 
Two segment regression time 
 
Level of block at the end of surgery 
 
Subarachnoid block – Delivery interval 
 
Uterine incision and delivery interval 
 
APGAR score: 1min ‐   5min – 
 
Duration of postoperative analgesia – 
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INTRAOPERATIVE MONITORING 
 
TIME  SENSORY 
LEVEL 
VAS  PULSE 
RATE 
BP SPO2 RESPIRATORY 
RATE 
SEDATION 
SCORE 
REMARKS
5 min 
 
10min 
 
15min 
 
30min 
 
45min 
 
1hr 
 
       
 
 
COMPLICATIONS 
 
HYPOTENSION  BRADY 
CARDIA 
PRURITIS NAUSEA & 
VOMITING
MUSCLE 
RIGIDITY
COMPLICATIONS 
OF BABY 
RESP. NIL
 
 
     
 
 
POSTOPERATIVE MONITORING 
 
TIME  SENSORY 
LEVEL 
VAS PAINFREE 
INTRAVAL 
REMARKS 
2hr 
 
4hr 
 
6hr 
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MASTER CHART 
MASTER CHART GROUP A  BASELINE  Max  Time  2 seg 
Moto
r 
PR  BP 
Sed 
Score 
Pain 
Free 
APGAR 
SL.N
O  NAME 
AGE  WT  HT  PR  BP  RR  SPO2 
Senl
ev 
Ma
x 
Se
n 
Reg 
time 
5 
min 
15 
min 
30 
min 
5 
min 
15 
min 
30 
min 
1 
min 
5 
min 
1  Maharasi  33  54  153  82  120  20  98  7  3  78  3  86  93  94  120  98  104  1  141  8  9 
2  Mantram  23  59  154  94  130  18  97  7  3  69  3  106  108  108  130  102  114  1  111  7  9 
3  Farida  18  63  162  80  120  18  97  7  2  75  3  84  104  106  120  130  130  1  133  7  9 
4  Murugama  19  56  151  93  110  18  98  7  4  64  3  96  104  93  110  90  104  0  100  7  10 
5  Sudali  27  62  149  86  120  19  97  6  3  78  3  90  97  90  120  92  108  0  123  7  9 
6  Devi  23  57  153  99  130  21  98  7  4  66  3  104  108  98  130  110  118  0  104  8  10 
7  Selvi  22  57  154  78  140  19  98  7  4  65  3  84  89  88  140  120  126  0  108  7  10 
8  Kalayani  26  59  159  78  110  18  98  6  4  58  3  82  93  90  110  90  102  1  100  8  10 
9  Malai  27  60  153  82  130  18  97  7  4  56  3  84  96  90  130  120  126  1  91  8  10 
10  Lakshmi  22  63  168  82  120  18  97  6  4  76  3  84  90  90  120  80  84  0  142  7  10 
11  Kokila  27  63  159  93  130  18  95  7  4  75  3  97  99  88  130  102  100  1  138  8  9 
12  Kumudava  21  55  150  93  140  17  96  6  4  55  3  96  96  84  140  120  120  1  93  8  9 
13  Paichiamma  25  59  158  78  130  18  97  7  3  80  3  84  84  90  130  108  110  0  158  7  9 
14  Muthu  23  49  168  84  110  19  97  7  3  69  3  86  93  104  110  108  118  0  123  8  9 
15  Sankaramm  32  59  151  82  110  18  98  5  5  77  3  88  93  90  110  90  98  1  135  8  9 
16  Sumathy  30  68  151  84  120  17  96  6  5  58  3  86  93  88  120  104  108  1  100  8  9 
17  Gomathi  22  56  152  92  140  18  96  5  5  66  3  98  102  98  140  100  108  1  124  8  9 
18  Muthulaksh  35  54  156  78  120  18  96  7  3  70  3  82  86  89  120  94  98  1  106  7  9 
19  Palammal  25  61  153  78  120  19  97  6  4  66  3  60  74  80  84  92  110  0  139  8  9 
20  Selvei  32  59  147  88  130  17  95  5  4  60  3  92  94  90  130  110  110  1  118  7  8 
21  Mariaamal  22  68  153  88  110  18  97  7  3  60  3  84  89  90  110  116  104  1  101  7  8 
22  Jagada  22  63  162  77  110  17  96  6  4  69  3  84  88  86  110  90  94  1  143  7  8 
23  Sasi  27  59  162  82  110  18  97  7  3  81  3  88  93  91  110  100  106  0  174  7  9 
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24  Judi  22  68  156  88  130  20  96  7  3  78  3  90  54  82  130  110  110  1  136  8  9 
25  Subbamal  22  53  149  86  110  18  97  6  5  74  3  86  92  92  110  92  70  0  130  7  10 
26  Ramalaka  22  52  142  82  110  18  97  4  4  73  3  84  86  72  110  80  76  1  151  8  9 
27  Sujatha  29  68  158  88  130  19  97  6  5  58  3  90  94  90  130  86  94  1  105  8  9 
28  Kayal  24  64  158  78  120  19  98  6  5  84  3  80  84  86  120  90  98  1  147  8  9 
29  Fathima  28  55  156  82  120  18  98  7  5  72  3  88  90  88  120  110  118  1  134  8  9 
30  Babitha  23  48  147  82  110  19  98  6  4  80  3  88  93  90  110  110  100  1  143  7  9 
31  Jenifrer  22  52  156  92  110  21  98  6  4  68  3  96  98  93  110  90  94  0  139  7  9 
32  Gomathi  20  52  154  86  120  18  97  7  5  81  3  89  93  102  120  114  110  0  162  8  9 
33  Pattu  21  56  153  84  120  20  98  6  4  84  3  86  93  92  120  100  106  0  186  8  9 
34  Kalayni  26  55  158  82  120  20  98  7  4  56  3  84  88  89  120  110  110  0  92  8  9 
35  Rajeshwari  21  59  153  88  130  19  98  6  5  56  3  88  93  94  130  110  118  1  98  7  10 
36  Essakiamm  19  59  162  93  140  18  97  8  4  58  3  96  97  98  140  130  120  1  102  8  9 
37  Papa  25  56  156  84  120  17  98  7  3  75  3  86  93  90  120  96  100  0  131  8  9 
38  Marriamma  24  59  168  82  110  18  98  8  4  68  3  88  90  86  110  110  106  0  126  7  10 
39  Maharasi  35  57  159  93  130  18  97  8  3  69  3  98  102  98  130  100  110  1  116  7  9 
40  Santha  20  63  169  84  120  19  98  7  3  73  3  86  93  90  120  94  96  0  131  8  10 
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MASTER CHART 
MASTER CHART GROUP B  BASELINE  Max  Time  2 seg  Motor  PR  BP  Sed Score  Pain Free  APGAR 
SL.N
O  NAME  AGE  WT  HT  PR  BP  RR 
SPO
2 
Se
nle
v 
Max 
Sen 
Reg 
time   
5 
min 
15 
min 
30 
min 
5 
min 
15 
min 
30 
min     
1 
min 
5 
min 
1  Arumuga  22  55  154  84  110  19  97  3  90  3  89  84  88  108  110  114  2  170  7  9 
2  Valarmat  27  48  154  88  130  19  97  4  100  3  98  98  82  90  112  114  2  195  7  8 
3  Priya  32  62  165  90  120  20  98  3  80  3  120  120  118  110  110  110  1  145  7  8 
4  Latha  22  48  152  90  110  20  99  3  70  3  92  91  93  110  100  90  1  163  8  9 
5  Kanaka  20  56  159  88  130  20  98  3  83  3  88  78  74  130  124  126  2  160  7  8 
6  Sudha  20  59  153  82  140  19  96  2  90  3  99  104  102  130  130  128  2  191  7  8 
7  Subbu  22  57  149  82  130  21  96  5  95  3  71  82  108  80  100  110  1  192  8  10 
8  Kanni  20  80  159  82  130  20  97  5  86  3  83  78  88  130  128  126  2  169  8  10 
9  Mupudath  27  82  159  88  120  21  96  3  91  3  82  88  93  130  122  132  1  172  7  8 
10  Anbu  21  78  156  97  130  20  97  4  92  3  98  93  92  118  130  128  1  183  8  9 
11  Kumudav  30  63  153  80  130  20  97  4  82  3  86  92  93  128  128  124  1  163  8  9 
12  Paichiam  20  63  151  88  120  20  98  4  88  3  96  102  93  132  128  116  1  175  8  9 
13  Muthu  25  62  149  88  120  19  97  3  83  3  93  98  88  126  132  122  1  175  8  9 
14  Sankara  25  57  154  84  140  18  99  5  87  3  98  92  98  122  130  118  1  174  7  8 
15  Sumathy  23  62  156  88  120  19  98  4  92  3  93  98  89  122  120  128  1  180  7  9 
16  Gomathi  32  59  153  80  120  18  97  3  82  3  86  92  93  122  112  112  1  165  7  9 
17  Muthulak  20  62  154  93  120  18  97  4  92  3  97  102  102  112  110  110  1  172  8  9 
18  Sudali  30  54  153  80  120  18  97  4  84  3  84  86  93  118  108  112  1  169  7  9 
19  Nila  27  55  147  82  114  18  97  3  92  3  78  92  96  104  114  118  1  172  8  9 
20  Dhanam  20  57  149  96  130  20  98  4  86  3  102  100  97  132  116  122  1  169  8  9 
21  Valli  24  74  156  86  110  17  96  2  89  3  96  104  88  100  106  100  1  177  7  9 
22  Lakshmi  23  48  147  88  100  18  95  3  94  3  104  104  102  94  94  96  1  190  7  9 
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23  Sangeetha  25  48  149  86  110  19  97  4  88  3  106  108  98  98  110  106  2  173  8  9 
24  Perumal  21  57  147  92  120  19  97  4  95  3  106  108  104  110  108  110  1  170  7  9 
25  Eassakith  28  68  159  93  110  19  97  4  89  3  104  93  94  104  112  112  1  183  8  9 
26  Parumu  21  62  154  84  110  19  95  4  94  3  93  106  98  108  104  108  2  186  8  9 
27  Susi  27  59  153  93  120  19  96  3  88  3  104  93  102  110  112  110  1  182  8  9 
28  Ganapath  23  62  156  78  110  19  96  4  89  3  90  100  89  118  108  110  1  172  7  9 
29  Syed  25  54  154  82  140  18  96  4  92  3  93  93  88  130  120  130  1  171  7  8 
30  Santhana  24  56  152  86  130  19  97  4  89  3  92  94  96  132  118  120  1  173  7  9 
31  Subbu  22  65  153  86  140  19  96  5  91  3  98  96  88  140  122  128  0  188  8  8 
32  Rekha  27  48  152  88  120  19  96  3  92  3  96  92  97  108  110  110  1  183  8  9 
33  Kalai  30  59  151  93  130  17  95  3  88  3  98  99  104  130  120  120  0  172  7  9 
34  Sugu  21  68  159  89  110  19  97  4  92  3  98  100  93  120  120  116  1  200  7  8 
35  Pavai  19  52  152  88  110  19  96  3  94  3  94  99  90  100  100  98  1  178  7  9 
36  Viji  22  60  158  82  130  18  98  3  86  3  84  98  94  118  128  116  1  183  7  9 
37  Alibath  28  54  162  82  120  21  98  4  92  3  88  92  94  114  124  118  1  171  7  9 
38  Mohana  26  57  159  78  130  18  97  3  94  3  80  92  84  130  120  120  2  182  8  9 
39  Thai  22  53  159  93  110  17  98  3  103  3  96  82  94  110  106  106  2  228  9  10 
40  Mari  20  54  159  84  120  18  98  3  95  3  88  98  90  120  124  108  2  214  8  9 
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MASTER CHART 
MASTER CHART GROUP C  BASELINE  Max  Time  2 seg 
Motor 
PR  BP 
Sed 
Score 
Pain 
Free 
APGAR 
SL.NO  NAME  AGE  WT  HT  PR  BP  RR  SPO2  Senlev  Max Sen 
Reg 
time 
5 
min 
15 
min 
30 
min 
5 
min 
15 
min 
30 
min 
1 
min 
5 
min 
1  Sumathai  27  52  164  88  120  21  99  4  101  3  88  90  84  120  110  110  2  220  7  9 
2  Kalai  25  63  154  88  110  21  98  2  105  3  92  86  89  110  110  110  2  218  7  9 
3  Prema  27  60  160  98  110  19  96  4  104  3  106  104  96  116  104  106  2  207  8  9 
4  Kavitha  21  54  153  88  120  19  96  5  104  3  108  114  108  108  120  120  2  217  7  8 
5  Sangetha  21  48  153  92  130  20  97  4  94  3  104  82  84  132  120  120  3  203  8  9 
6  Pradeepa  21  54  153  84  120  18  96  4  107  3  93  96  88  124  114  108  2  242  7  9 
7  Devi  26  63  156  90  130  18  96  5  94  3  92  94  88  130  120  120  2  206  8  9 
8  Vadivoo  25  72  168  88  110  18  95  5  98  3  96  96  89  110  104  106  2  294  7  9 
9  Kuthalam  25  59  156  78  120  19  98  5  98  3  88  88  85  124  112  108  2  215  8  9 
10  Kalayni  22  63  151  88  120  19  96  4  99  3  96  96  88  124  116  114  2  211  7  9 
11  Rajeshwari  29  68  159  88  130  18  96  5  102  3  88  96  84  130  118  122  2  205  8  9 
12  Essakiamm  32  57  156  84  110  20  97  4  98  3  96  102  98  106  112  110  2  244  8  9 
13  Papa  22  54  151  78  130  20  97  5  109  3  90  94  88  130  120  120  3  215  8  9 
14  Marriamm  29  45  154  92  130  19  97  5  98  3  104  59  84  116  84  106  3  211  8  9 
15  Maharasi  21  58  153  80  130  18  95  4  109  3  86  90  88  128  132  120  2  239  7  9 
16  Dhanam  26  62  162  78  130  19  97  4  104  3  88  84  82  130  118  120  3  222  7  9 
17  Rosy  23  50  156  92  110  18  97  5  92  3  96  98  102  110  70  86  2  256  7  9 
18  Suleka PV  30  56  147  78  120  17  96  5  109  3  82  88  84  120  108  100  2  168  8  9 
19  Subbu  22  68  176  82  130  17  97  3  83  3  88  93  93  130  118  122  2  240  8  9 
20  Kanni  20  64  159  82  130  19  97  5  108  3  86  92  98  130  118  120  2  266  7  9 
21  Mupudathi  21  69  156  88  130  20  97  5  112  3  93  97  88  130  112  114  2  205  7  9 
22  Anbu  30  59  156  93  120  18  96  3  98  3  102  104  98  120  130  118  1  255  8  9 
23  Kumudava  25  51  146  92  110  18  96  5  117  3  90  88  83  110  96  98  3  211  7  9 
24  Mari Priya  27  62  158  74  130  18  96  4  88  3  79  84  86  130  118  120  1  172  7  9 
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25  Vishalathc  25  63  169  82  130  18  97  4  94  3  88  93  92  130  134  118  2  218  8  9 
26  Jothi  23  68  153  78  120  19  96  4  104  3  86  88  83  124  108  110  2  190  7  9 
27  Kanmani  32  62  156  88  120  18  97  4  95  3  73  96  94  120  108  110  2  220  8  9 
28  Kaviya  23  59  163  82  110  18  95  5  112  3  86  93  92  110  102  100  3  216  8  9 
29  Kiruthika  30  64  158  93  120  18  96  4  98  3  96  98  93  124  118  108  2  246  8  9 
30  Maheswar  29  59  154  82  120  18  97  2  89  3  86  90  88  120  102  102  3  205  7  9 
31  Malathi  27  73  169  88  130  18  97  5  82  3  92  93  88  130  118  120  1  181  8  9 
32  Meera  24  63  156  78  120  19  97  3  96  3  80  83  78  120  118  106  2  174  8  9 
33  Bhagyam  30  59  153  74  130  18  96  5  113  3  83  86  86  130  118  122  2  194  7  9 
34  Pattu  20  68  159  92  120  18  96  4  99  3  93  94  98  120  124  108  2  253  7  9 
35  Kalayni  28  62  159  82  120  18  96  4  104  3  86  90  88  120  126  110  2  225  8  9 
36  Rajeshwar  22  41  145  80  110  18  97  5  110  3  82  84  82  104  104  104  2  218  8  10 
37  Essakiam  20  48  147  82  110  19  97  5  112  3  90  92  88  116  104  102  2  245  7  9 
38  Bharkavi  23  59  153  82  130  18  98  4  104  3  86  88  86  120  100  104  2  251  7  9 
39  Latha  29  64  161  92  120  18  97  5  98  3  96  96  94  130  110  110  2  284  8  10 
40  Jaya  33  63  159  88  110  18  97  4  104  3  90  93  90  100  110  100  3  201  7  9 
 
 
